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Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is 
spread from person to person, predominantly through respiratory 
droplets and contact with contaminated surfaces,[1] and possibly 
through airborne transmission.[2] Consequently, close contact 
with infected people should be avoided. Transmission risk may be 
mitigated by wearing personal protective equipment (PPE) such as 
face masks.
The pandemic has led to global shortages of PPE, including 
masks and respirators. Masks are critical to protecting healthcare 
workers from becoming infected and from infecting patients.[1] 
Masks have also been widely promoted for preventing transmission 
in community settings. This is particularly relevant for SARS-CoV-2, 
since pre-symptomatic transmission may be important.[3]
Guidance from global oversight bodies varies. At the start of the 
pandemic, the World Health Organization (WHO) noted in April 
2020 that there was insufficient evidence to support mask use, 
with uncertainties about risks for healthy people in the community 
setting.[1] The WHO offered advice to decision-makers to consider 
the following before using masks in communities: (i) the rationale 
and reason for mask use must be clear; (ii) SARS-CoV-2 exposure 
risk in the community; (iii) population vulnerability to develop 
severe disease or mortality risk; (iv) population setting and ability 
to implement social distancing; (v) feasibility in terms of mask use 
costs, availability and tolerability; and (vi) mask type. The potential 
risks should also be considered, particularly diversion of medical 
mask supplies from essential service personnel such as healthcare 
providers. Regarding non-medical cloth masks, the WHO advised 
in June 2020 that decision-makers apply a risk-based approach and 
recommended the use of these masks in some situations such as in 
communities with widespread transmission and when there’s limited 
space for physical distancing. Cloth masks should be used together 
with handwashing, cough and sneezing etiquette, and physical 
distancing as key to reducing transmission.[1]
The US Centers for Disease Control and Prevention (CDC) 
changed its guidance on 6 April 2020 regarding mask use for the 
general public by issuing a directive to ‘cover your mouth and 
nose with a cloth face cover when around others’.[4] For healthcare 
workers, they recommended the use of homemade masks as a last 
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
Rapid review of the effects of cloth and medical 
masks for preventing transmission of SARS-
CoV-2 in community and household settings
T Chetty,1,2 MB ChB, FCPHM (SA), MMed, PhD; V Ramokolo,1,2 BSc (Hons), MPH, PhD; K Rees,3 MB BCh, FCPHM (SA); T Kredo,4,5 MB ChB, 
MMed (Clin Pharm), PhD; Y Balakrishna,6 MSc; C Mathews,1 BA, MSc, PhD; N Siegfried,1 MB ChB, MPH (Hons), FCPHM (SA), PhD
1 Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa
2 HIV Prevention Research Unit, South African Medical Research Council, Cape Town, South Africa
3  Department of Community Health, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,  
South Africa
4 Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa
5  Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town,  
South Africa
6 Biostatistics Unit, South African Medical Research Council, Durban, South Africa 
Corresponding authors: T Chetty (terusha.chetty@mrc.ac.za) and V Ramokolo (vundli.ramokolo@mrc.ac.za)
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illnesses (relative risk (RR) 1.56; 95% confidence interval (CI) 0.98 - 2.49) and laboratory-confirmed respiratory virus infections (RR 1.54; 
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certainty evidence that medical masks may make little to no difference to ILI infection risk versus no masks (RR 0.98; 95% CI 0.81 - 1.19) 
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(RR 0.81; 95% CI 0.55 - 1.20) in the household setting. 
Conclusions. Direct evidence for cloth and medical mask efficacy and effectiveness in the community is limited. Decision-making for 
mask use may consider other factors such as feasibility and SARS-CoV-2 transmission dynamics; however, well-designed comparative 
effectiveness studies are required.
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resort, with a warning that their protective capacity is unknown and 
homemade masks should not be classified as PPE.[5] The CDC further 
recommended that medical masks or respirators be prioritised for 
healthcare providers and not be used by the general public.[6]
Evidence of the effectiveness of the cloth mask arises mainly from 
in vitro filtration studies, which showed that cloth masks may offer 
some protection from respiratory pathogens, despite substantially 
lower filtration ability compared with surgical masks.[7] Factors that 
may affect filtration include cloth type, stretching and the manner of 
mask washing.[8] In a simulation study assessing prevention of airborne 
particle expulsion, cloth masks offered marginal protection, with 
substantially better protection offered by medical masks.[9] However, 
data from another simulation study reported that wearing any face 
mask reduces the distance travelled by a person’s breath by more than 
90%.[10] Further, all face masks without an outlet valve substantially 
minimised the ejection of air through a front flow jet. However, both 
medical and homemade cloth masks generate backward and sideways 
jets that may be hazardous to those behind or beside wearers.[10]
Widespread wearing of any type of mask has been proposed 
to reduce discrimination by limiting the identification of persons 
with SARS-CoV-2 infection. It has been further postulated that 
wearing a mask will limit face touching and create more general 
awareness. [11] Researchers have argued that health agencies consider 
asking the public to wear masks, even without strong evidence, due 
to the urgency of the pandemic and the need to distinguish between 
absence of evidence and evidence of absence.[12]
At the time of writing this review in early April 2020, guidance 
on the use of cloth and medical masks in the South African general 
population and households (community settings) was urgently 
needed to enable decision-makers to ensure evidence-based policies 
about preventing community transmission without depleting 
essential PPE stocks for healthcare workers. Since that time, face-
coverings have been mandated for use in public; however, the 
need for strong evidence-based measures to prevent community 
transmission remains.
We conducted two rapid reviews of the evidence to quantify the 
effectiveness of cloth and medical masks in reducing the risk of 
SARS-CoV-2 transmission in community settings in April 2020. 
These informed evidence-based recommendations produced by the 
College of Public Health Medicine of South Africa (http://medat.
samrc.ac.za/index.php/catalog/42).
Methods
We used a prespecified protocol following the Cochrane guidelines 
for rapid reviews.[13]
Eligibility criteria were developed a priori and applied throughout 
the screening process. The intervention was masks (cloth or medical) 
compared with no mask or other types of masks in community 
settings (general populations or households) with the primary 
outcomes of clinical or laboratory-confirmed respiratory illness. 
RCTs were included and non-controlled observational studies, 
editorials, guidelines and public press articles were excluded.
We searched three electronic databases (PubMed, Embase and 
the Cochrane Library) and two trials registries (www.clinicaltrials.
gov/ and https://www.who.int/ictrp/en/) without language or date 
restrictions and not limited by terms for SARS-CoV-2, as this was 
early in the pandemic. The strategy is available on request. The 
search strategy was developed and conducted by an experienced 
information specialist on 30 and 31 March 2020. All records were 
uploaded into EndNote.
Records were screened independently in duplicate to identify 
eligible studies and the full-text articles were then obtained. Eligibility 
assessment, data extraction and assessment was conducted with 
the Cochrane risk of bias 2.0 tool (https://sites.google.com/site/
riskofbiastool/welcome/rob-2-0-tool?authuser=0) were conducted 
in duplicate and independently.[14] Any disagreements were resolved 
through discussion or in consultation with a third reviewer (NS).
Where data permitted pooled synthesis, we conducted a meta-
analysis using the generic inverse variance option in REVMAN 
(https://training.cochrane.org/online-learning/core-software-
cochrane-reviews/revman) to combine adjusted estimates of effects 
using the random-effects model. Where reports of cluster trials did 
not include an intra-cluster correlation coefficient, we adjusted the 
variance accordingly and conducted a sensitivity analysis of both 
the reported and adjusted results to ascertain the robustness of the 
meta-analysis.
We conducted a grading of recommendations, assessment, 
development and evaluation (GRADE) assessment to establish the 
certainty of the evidence across each outcome, taking into account risk 
of bias, directness, consistency, precision, and other considerations 
such as publication bias to determine whether the confidence in the 
overall results was high, moderate, low or very low.[15]
Results
There were 821 unique articles retrieved and screened from three 
databases. Nine studies were assessed for eligibility, from which one 
RCT was identified for cloth masks and seven RCTs for medical 
masks. No SARS-CoV-2-specific studies were identified and as a 
result, we included studies which included other viral respiratory 
illnesses (Fig. 1). More detailed study data are available elsewhere 
(http://medat.samrc.ac.za/index.php/catalog/42).
No additional studies were identified from www.clinicaltrials.
gov or the dedicated COVID-19 WHO international clinical 
trials registry platform (ICTRP) (https://www.who.int/ictrp/en/). 
Reference screening from systematic reviews did not yield additional 
studies. 
Cloth mask review
Characteristics of the included RCT
No eligible studies were identified for cloth mask use in the 
community setting or SARS-CoV-2 infection. A cluster RCT 
conducted in healthcare workers was included to provide indirect 
evidence. Seventy-four wards across 15 hospitals in Hanoi, 
Vietnam[16] were randomised to adopt cloth masks, medical masks, 
or usual practice (a mixture of medical, cloth and no masks) for 
their healthcare workers. The study compared continuous mask use 
in a medical mask group (two new masks per day) with a cloth mask 
group (five masks for the entire 4-week period). We do not report 
on the control group, which used masks in compliance with existing 
hospital protocols as a high proportion of participants donned both 
medical and cloth masks (53%; n=245/458). Participants in the 
medical mask (n=580) and cloth mask (n=569) arms were required 
to wear masks all day.
Clinical respiratory illness (CRI) (two or more respiratory 
symptoms or one respiratory symptom and a systemic symptom), 
influenza-like illness (ILI) (fever ≥38°C plus one respiratory 
symptom) and laboratory infections were assessed. Viral respiratory 
infection was confirmed in the laboratory by detecting nucleic 
acids using multiplex reverse transcriptase PCR (RT-PCR) for 
17  respiratory viruses: respiratory syncytial virus (RSV) A and B, 
human metapneumovirus (hMPV), influenza A (H3N2), (H1N1) 
pdm09, influenza B, parainfluenza viruses 1 - 4, influenza C, 
rhinoviruses, SARS-CoV, coronaviruses 229E, NL63, OC43 and 
HKU1, adenoviruses and human bocavirus (hBoV).
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Healthcare workers kept diary records and monitored their 
temperature daily for 5 weeks. Symptomatic participants were 
swabbed for infection on the reporting day. Medical masks consisted 
of non-woven material, three-layered and locally sourced. Cloth 
masks were cotton and two-layered.
We judged the trial to be at low risk of bias. The lack of participant 
and researcher intervention blinding was a possible source of 
both measurement and detection bias, but this was mitigated by 
thermometer measurement and laboratory confirmation for positive 
symptoms.
Evidence of effects
Using the GRADE approach, the overall evidence certainty for all 
outcomes was marked down for indirectness as the trial randomised 
masks in healthcare workers and not the general public. The rhinovirus, 
which is airborne and can also be spread in droplets, was identified as 
the main virus. We did not deem the lack of coronavirus-specific 
infections to warrant for further mark down for indirectness (Table 1).
Clinical respiratory illness 
In the crude analysis, there is moderate certainty that participants 
wearing cloth masks were probably more likely to exhibit CRI than 
those wearing medical masks (relative risk (RR) 1.57; 95% confidence 
interval (CI) 0.99 - 2.48). The effect remained similar even after 
adjusting for clustering (RR 1.57; 95% CI 0.87 - 2.84) and clustering 
and confounders (RR 1.56; 95% CI 0.98 - 2.49).
Influenza-like illness 
There is very low certainty that participants wearing cloth masks 
may be more likely to exhibit ILI than those wearing medical masks 
(RR 13.25; 95% CI 1.74 - 100.96). The very low certainty was caused 
by the imprecision in the data due to the very low event rate and 
resultant wide confidence interval. The effect remained similar even 
after adjusting for clustering (RR 13.25; 95% CI 0.98 - 179.90) and 
clustering and confounders (RR 13.00; 95% CI 1.69 - 100.03).
Laboratory-confirmed viruses
Among the 68 laboratory-confirmed cases, 85% (n=58) were 
rhinoviruses. There is moderate certainty that participants wearing 
cloth masks were more likely to have laboratory-confirmed viral 
illness v. medical masks (RR 1.66; 95% CI 0.95 - 2.91). The effect 
remained the same even after adjusting for clustering (RR 1.66; 
95% CI 0.81 - 3.40), and clustering and confounders (RR 1.54; 95% 
CI 0.88 - 2.70).
Compliance with wearing masks and adverse effects
There is moderate certainty that compliance in both groups was 
probably the same (RR 1.00; 95% CI 0.90 - 1.11). Both groups were 
56% compliant. The proportion of participants who complained of 
discomfort was 42.6% in the group wearing cloth masks compared 
with 40.4% in those wearing surgical masks. There is moderate 
certainty that discomfort in both groups was the same (RR 1.05; 95% 
CI 0.92 - 1.21).
Medical mask review
Seven RCTs met the inclusion criteria for the medical mask review.
Characteristics of the included RCTs
Community settings
Two cluster RCTs evaluated medical mask effectiveness for protection 
against ILI in a university student population. Healthy students living 
in residence received medical masks and instructions on their use, 
and the control group received no masks.[17,18] The ILI rate was 
evaluated across the student population.
Records found in 
PubMed (n=541)
Records found in 
Cochrane Library (n=16)
Records found in the 
Cochrane Central Register of 
Controlled Trials (CENTRAL) 
(n=388)
Records found in 
Embase (n=132)
Duplicates (n=256) Records screened (N=821) Duplicates (n=256)
Medical mask review
2 full-text articles excluded as 
one trial evaluated cloth masks 
and another compared types 
of masks (respirator v. medical)
9 full-text articles 
assessed for eligibility
Cloth mask review
8 full-text articles excluded 
as all the trials included 
surgical or respirator masks 
and not cloth masks
Medical mask review 
7 studies included in the quantitative 
synthesis for the medical mask review
Cloth mask review 
1 study included in the quantitative and qualitative 
synthesis for the cloth mask review
Fig. 1 PRISMA flow diagram of the search. 
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Household settings
Four cluster RCTs evaluated medical 
mask effectiveness for protecting 
household members from acquiring ILI 
infection from an infected member.[19-22] 
Only the ill household member was 
given a mask in two RCTs,[19,21] the 
ill participant and all other members 
of the household were provided with 
masks in the third trial,[20] and the 
ill participant and all household 
members who became ill during the 
study follow-up were advised to wear 
masks in the fourth trial.[22] The fifth 
RCT was conducted among pilgrims 
attending Hajj, and both the pilgrims 
with ILI symptoms and those sleeping 
near them were given masks.[23]
Evidence of effects 
Community settings
There is low-certainty evidence that 
there may be little or no difference in 
transmission between participants (mask 
group n=735; no mask group n=834) 
wearing medical masks and those not 
wearing medical masks (RR 0.98; 95% 
CI 0.81 - 1.19) in two trials (Fig. 2).[17,18] 
The low certainty is due to the probable 
risk of performance bias, as participants 
were not blinded and the assessment of 
the outcome relied on participant self-
reported flu-like symptoms (possible 
detection bias). Furthermore, the trials 
were conducted by the same investigators 
over two seasons using a single protocol 
and may therefore have limited 
generalisability to community settings 
other than universities. We downgraded 
these trials for indirectness (Table 2).
Household settings
There is low-certainty evidence that 
participants (mask group n=690; no 
mask group n=719) wearing medical 
masks were less likely to have ILI than 
those not wearing medical masks 
(RR 0.81; 95% CI 0.55 - 1.20) in five 
trials (Fig. 3).[17,18] The low certainty 
is partly due to imprecision because 
the confidence interval of the point 
estimate includes the null effect, 
appreciable benefit and some harm. 
The low certainty is also due to the 
high risk of performance bias because 
study participants were not blinded. 
The assessment of the outcomes relied 
on self-reported flu-like symptoms 
(possible detection bias).
As no adjustment for clustering 
was reported in the Barasheed 
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variance assuming an intraclass correlation coefficient (ICC) 
of 0.2 that was informed by the Suess et al.[22] trial and an 
average cluster size of 6 based on the Barasheed et al.[23] trial. 
Based on the aforementioned assumptions, we conducted a 
sensitivity analysis with and without the Barasheed et al.[23] 
trial in the meta-analysis and found a similar estimate of effect 
(RR 0.88; 95% CI 0.57 - 1.36).
Compliance in community settings
One trial reported that those wearing masks did so for an average 
(standard deviation (SD)) of 5.04 (2.2) hours per day,[18] while no 
compliance data were reported in the other trial.[17] Neither of the 
trials reported adverse effects.
Compliance in household settings
Compliance among trials varied. In the trials where only the ill 
household member wore a mask, the index patients reported wearing 
masks on average (SD) 3.7 hours (2.7) a day[19] and for 4.4 hours (95% 
CI 3.9 - 4.9) in the MacIntyre et al.[21] trial. Notably, in the latter trial, 
patients in the no-mask control arm also wore masks for an average 
of 1.4 hours (95% CI 0.9 - 1.8). In the Hajj-based trial, face mask 
compliance by pilgrims in the mask group was 76% (n=56/75), and 
12% (n=11/89) in the no-mask control group.[23]
In the trials where both the ill household member and the rest of 
the household members were given masks, compliance was low in 
one of the trials, with more than 25% of the household contacts in the 
face-mask group not wearing a surgical mask at all during the follow-
up period.[20] Moreover, more than 25% of index cases in the control 
and hand hygiene intervention arms reported wearing masks at home 
on their own accord, possibly contaminating the intervention. In the 
other trial where household contacts were advised to wear a mask 
only when they became ill, daily adherence was generally moderate 
and reached a plateau of over 50%.[22]
Three trials reported adverse effects. In the trial by Canini et al.[19] 
three-quarters (75%, n=38) of the patients from the intervention 
arm reported discomfort with mask use, and the three main causes 
of discomfort were warmth (45%), respiratory difficulties (33%) and 
humidity (33%). Children wearing masks reported feeling pain more 
frequently (n=3/12) than other participants wearing masks (n=1/39).[19] 
In a trial by Suess et al.[22] adults (35%; n=10/29) and children 
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Fig. 2. Medical mask review: Forest plot for influenza-like illness in the community setting. (RR = risk ratio; SE = standard error; IV = inverse variance; 
CI = confidence interval.)
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Fig. 3. Medical mask review: Forest plot for influenza-like illness in the household setting. (RR = risk ratio; SE = standard error; IV = inverse variance; 
CI = confidence interval.)
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(53%; n=18/34) complained about the heat/
humidity, followed by pain and shortness of 
breath when wearing a mask. Finally, a trial 
conducted by Barasheed et al.[23] reported 
that the most common reason for not 
wearing a face mask was discomfort (15%).
A sensitivity analysis including a more 
complete analysis of one of the studies[24] 




No RCTs specific for the prevention 
of transmission of SARS-CoV-2 in the 
community were identified for either 
medical or cloth masks. A single cluster 
RCT among healthcare workers comparing 
medical masks with cloth masks provided 
indirect evidence to the general population, 
indicating that cloth-mask users were 
probably more likely to exhibit CRI or ILI 
v. medical masks users with a moderate 
and low degree of certainty, respectively. 
Furthermore, users wearing cloth masks may 
be more likely to have laboratory-confirmed 
virus infections compared with wearers of 
medical masks.
In the medical-mask review, evidence 
from two trials assessing respiratory viral 
infections indicated that wearing medical 
masks may not be effective in preventing 
widespread community transmission of ILI. 
Data from five trials indicated that wearing 
medical masks may prevent transmission 
of ILI from ill to healthy members of the 
households. The generalisability of these 
results to the current SARS-CoV-2 pandemic 
remains unclear but at the onset of the 
epidemic in April 2020, they were deemed 
to provide reasonable indirect evidence to 
inform policy and guidance.
A recent systematic review by Jefferson 
et al.[26] updated a previous Cochrane 
review assessing the effectiveness of medical 
masks,[25] included 9 RCTs investigating the 
effect of masks in healthcare workers and the 
general population, and concluded that there 
is a lack of evidence for a protective effect of 
medical masks in all populations. However, 
their meta-analysis of the effect of masks on 
ILI and lab-confirmed influenza included 
trials in both the general population and 
healthcare settings. The separate effect of 
masks on ILI was only presented for the 
healthcare setting. Our results differ as we 
excluded trials conducted in healthcare 
settings, we sub-grouped trials by household 
and community setting rather than 
combining these, adjusted for clustering 
where necessary, and conducted sensitivity 
analysis due to the assumptions made in 
our clustering analyses. Importantly, our 
interpretation of the evidence, which 
included a GRADE assessment, differs to 
their conclusion as we concluded that in 
the household setting, medical masks may 
provide some protection to other members 
of the household.
In a recent systematic review and meta-
analysis of observational studies evaluating 
measures to reduce SARS-CoV-2 and 
beta coronaviruses, a physical distance of 
a minimum 1 m was strongly associated 
with reduction of infection risk and a 
distance of 2 m was more effective. Data 
indicated that disposable surgical masks or 
reusable 12 – 16-layer cotton face masks 
were associated with protection, even in 
non-healthcare settings for the general 
public. No intervention, even when 
properly used, was associated with complete 
protection from infection.[27] Other basic 
measures such as hand hygiene are still 
needed with physical distancing, face 
masks and eye protection. These data also 
highlighted a need for further research on 
the effectiveness of different combinations of 
bundled interventions including variations 
in masks, physical distancing, handwashing 
and others as SARS-CoV-2 transmission 
dynamics are likely to change in different 
community settings depending on factors 
such as population density and the size of the 
population at risk. These interventions need 
to also be assessed for their acceptability, 
affordability and impact on social, economic 
and environmental endpoints in addition to 
clinical outcomes.
Our rapid review findings highlight the 
urgent need for community-based controlled 
studies that compare the effectiveness of 
different facial coverings on mitigating the 
acquisition of SARS-CoV-2. Furthermore, 
given the possibility of subsequent COVID-
19 waves, more comprehensive systematic 
reviews need to be conducted as new 
evidence becomes available.
There were several limitations in both 
rapid reviews. Firstly, only one trial was 
identified for the review assessing cloth 
masks v. medical masks and usual practice.[16] 
The RCT was not community-based, provi-
ding only indirect evidence. However, the 
RCT design is one of the study strengths 
and we assume that the confounders and 
effect modifiers were equally distributed 
between trial arms. The authors of the 
study noted that ‘the finding of a much 
higher rate of infection in the cloth mask 
group could be interpreted as harm caused 
by cloth masks, the efficacy of medical 
masks, or most likely a combination of 
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self-contamination through repeated and improper doffing and 
handwashing techniques. Prior modelling studies have quantified 
the contamination level of face masks[28] and viruses may survive 
on the surface of face masks.[29] Pathogen transfer from cloth 
or medical masks to the bare hands of the wearer is plausible 
if doffing techniques in the RCT were inappropriate. Notably, 
the study did not have a no-mask control group because it was 
deemed unethical to ask participants not to wear a mask, and the 
control group followed standard practice, which may or may not 
have included mask use.
In the medical-mask review, the two community-based trials 
assessing the effectiveness of medical masks v. no masks in preventing 
ILI acquisition took place at university residences. This limits 
the generalisability of the findings to community settings other 
than university residences, so the evidence was downgraded for 
indirectness. In the trials of household transmission, mask-wearing 
compliance varied, with some participants in the no-mask control 
group also wearing masks, signalling contamination and potentially 
reducing the estimate of effectiveness.
Wearing of masks has become highly politicised and polarised 
and was complicated by concerns that widespread wearing of 
medical masks by the general population may result in a shortage 
of masks for healthcare workers. To our knowledge, little attention 
has been given to considerations around the provision of what is 
optimal for individual and population health, rather than what is 
currently possible, feasible or necessary. Greenhalgh et al.[30] argues 
that traditionally designed studies may not be suitable for assessing 
the complexity of health services and systems and that there is a 
moral argument for applying the ‘precautionary principle’ of acting 
in the absence of evidence given the potential protective benefit of 
face masks in the face of rising COVID-19 mortality. Traditional 
studies should be complemented by studies which account for the 
instability and ‘emergent causality’ in a real-world setting allowing for 
adaptation to changing contexts.[31] 
Chu et al.[27] recommend robust randomised trials of the 
effectiveness of several mask types in a community setting 
and for healthcare workers’ protection. However, the authors 
also acknowledge that scientific uncertainty and contextual 
considerations require a more nuanced approach. However, 
Greenhalgh et al.[31] argued that the ‘search for perfect evidence 
may be the enemy of good policy’ and they proposed conducting 
two natural experiments: one to determine compliance with proper 
mask use and the second to overcome mask shortages by repurposing 
manufacturing capacity. If research confirms that wearing of 
medical masks is more protective than cloth masks in a community 
setting, greater advocacy for increasing manufacturing of sufficient 
medical masks for widescale distribution is warranted in the context 
of the current pandemic. Preparedness for the ongoing spread 
of the pandemic and future pandemics should include measures 
to scale-up global manufacturing of masks of proven efficacy, 
efficient supply chains and mitigation of environmental threats 
posed by disposable masks. Improved materials for cloth masks 
are therefore also an urgent consideration, but these need to be 
tested in comparative effectiveness studies in community settings. 
Like with the harmonisation of current SARS-CoV-2 vaccine 
and treatment trials,[32] studies testing the effectiveness of these 
masks will need to consider a harmonised approach to facilitate 
evidence synthesis. We believe these are urgently needed in South 
Africa to determine the specificities to our setting, the additional 
implementation considerations around appropriate contextual 
messaging and feasibility.
Conclusions
There is currently no evidence from RCTs demonstrating that the 
use of cloth or medical masks prevents the transmission of SARS-
CoV-2 in the community setting. Indirect evidence from a single 
trial indicates that wearing cloth masks is associated with a higher 
risk of respiratory illness compared with medical masks. Medical 
masks may offer some protection to prevent household transmission 
of respiratory viral illnesses. The lack of direct evidence supportive 
of the efficacy, effectiveness and safety of masks in the community 
setting is an obstacle to evidence-based decision-making, particularly 
with a possible increase in emergent infectious viruses. There is a 
scope for comparative research into better-designed cloth masks 
and a need of controlled studies evaluating the efficacy of medical v. 
cloth masks conducted in the community setting where effects can be 
monitored, and potential harms identified early. 
Declaration. None.
Acknowledgements. We would like to thank Alishka Rajman, Dishiki 
Kalonji, Jim Te Water Naude, Rene English, Kerrin Begg, Solange Durao, 
Bey-Marrie Schmidt and Ameer Hohlfeld for participating in the review 
of medical masks and independently conducting duplicate risk of bias 
assessments. Joy Oliver developed and conducted the search strategy. The 
rapid reviews were conducted to inform guidance documents developed 
by the College of Public Health Medicine of South Africa COVID-19 
Evidence-based Task Team and were approved by the Colleges of Medicine 
of South Africa (http://medat.samrc.ac.za/index.php/catalog/42).
Author contributions. NS developed the protocol. TC and TK 
independently screened the records to identify eligible studies. KR, 
NS, CM and VR conducted duplicate data extraction and risk of bias 
assessment. NS conducted analysis and YB advised on adjusted statistical 
analysis. NS and TK conducted GRADE assessment. TC and VR wrote the 
draft manuscript. TC and VR contributed equally to the manuscript. All 
the authors approved the manuscript for publication. 
Funding. None.
Conflicts of interest. None.
1. World Health Organization. Corrigendum: Advice on the use of masks in the context of COVID-19: 
Interim guidance, 5 June 2020. Geneva: WHO, 2020. https://www.who.int/docs/default-source/
coronaviruse/corrigendum-to-ig-2020-4-ipc-masks-2020-06-05-pp-15-16-2020-06-06-e.
pdf?sfvrsn=c5992b89_22020 (accessed 9 June 2020).
2. Morawska L, Milton DK. It is time to address airborne transmission of COVID-19. Clin Infect Dis 
2020:71(9):2311-2313. https://doi.org/10.1093/cid/ciaa939
3. Wycliffe E, Wei M, Zongbin L, et al. Presymptomatic transmission of SARS-CoV-2 – Singapore, 
January 23 - March 16 2020. Morb Mortal Wkly Rep 2020;69(14):411-415. https://doi.org/10.15585/
mmwr.mm6914e1
4. Centers for Disease Control and Prevention. How to protect yourself and others. Atlanta: CDC, 2020. 
https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html (accessed 6 May 2020).
5. Centers for Disease Control and Prevention. Strategies for optimising the supply of facemasks. 
Atlanta: CDC, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html 
(accessed 6 May 2020).
6. Centers for Disease Control and Prevention. Use personal protective equipment (PPE). Atlanta: CDC, 
2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/using-ppe.html (accessed 9 June 2020).
7. Davies A, Thompson K, Giri K, Kafatos G, Walker J, Bennett A. Testing the efficacy of homemade 
masks: Would they protect in an influenza pandemic? Disaster Med Public Health Prep 2013;7(4):413-
418. https://doi.org/10.1017/dmp.2013.43
8. Neupane BB, Mainali S, Sharma A, Giri B. Optical microscopic study of surface morphology and 
filtering efficiency of face masks. Peer J 2019;7:e7142. https://doi.org/10.7717/peerj.7142
9. Van der Sande M, Teunis P, Sabel R. Professional and homemade face masks reduce exposure 
to respiratory infections among the general population. PLoS ONE 2008;3(7):e2618. https://doi.
org/10.1371/journal.pone.0002618
10. Viola IM, Peterson B, Pisetta G, et al. Face coverings, aerosol dispersion and mitigation of virus 
transmission risk. AarXiv:200510720 2020. 
11. Leung CC, Lam TH, Cheng KK. Mass masking in the COVID-19 epidemic: People need guidance. 
Lancet 2020;395(10228):945. https://doi.org/10.1016/S0140-6736(20)30520-1
12. Feng S, Shen C, Xia N, Song W, Fan M, Cowling BJ. Rational use of face masks in the COVID-19 
pandemic. Lancet Respir Med 2020;8(5):434-436. https://doi.org/10.1016/S2213-2600(20)30134-X
13. Garritty C, Gartlehner G, Kamel C, et al. Interim guidance from the Cochrane rapid reviews methods 
group. J Clin Epidimiol 2020;130:13-22. https://doi:10.1016/j.jclinepi.2020.10.007
14. Sterne JAC, Savovic J, Page MJ, et al. RoB 2: A revised tool for assessing risk of bias in randomised 
trials. BMJ 2019;366:4898. https://doi.org/10.1136/bmj.l4898
RESEARCH
234       March 2021, Vol. 111, No. 3
15. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of 
evidence and strength of recommendations. BMJ 2008;336(7650):924-926. https://doi.org/10.1136/
bmj.39489.470347.AD
16. MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with 
medical masks in healthcare workers. BMJ Open 2015;5(4):e006577. https://doi.org/10.1136/
bmjopen-2014-006577
17. Aiello AE, Murray GF, Perez V, et al. Mask use, hand hygiene, and seasonal influenza-like illness 
among young adults: A randomised intervention trial. J Infect Dis 2010;201(4):491-498. https://doi.
org/10.1086/650396
18. Aiello AE, Perez V, Coulborn RM, Davis BM, Uddin M, Monto AS. Facemasks, hand hygiene, and 
influenza among young adults: A randomised intervention trial. PLoS ONE 2012;7(1):e29744. https://
doi.org/10.1371/journal.pone.0029744
19. Canini L, Andreoletti L, Ferrari P, et al. Surgical mask to prevent influenza transmission in 
households: A cluster randomised trial. PLoS ONE 2010;5(11):e13998 https://doi.org/10.1371/journal.
pone.0013998
20. Cowling BJ, Fung RO, Cheng CK, et al. Preliminary findings of a randomised trial of non-
pharmaceutical interventions to prevent influenza transmission in households. PLoS ONE 
2008;3(5):e2101. https://doi.org/10.1371/journal.pone.0002101
21. MacIntyre CR, Zhang Y, Chughtai AA, et al. Cluster randomised controlled trial to examine medical 
mask use as source control for people with respiratory illness. BMJ Open 2016;6(12):e012330. https://
doi.org/10.1136/bmjopen-2016-012330
22. Suess T, Remschmidt C, Schink SB, et al. The role of facemasks and hand hygiene in the prevention of 
influenza transmission in households: Results from a cluster randomised trial; Berlin, Germany, 2009 - 
2011. BMC Infect Dis 2012;12:26. https://doi.org/10.1186/1471-2334-12-26
23. Barasheed O, Almasri N, Badahdah AM, et al. Pilot randomised controlled trial to test effectiveness of 
facemasks in preventing influenza-like illness transmission among Australian Hajj pilgrims in 2011. 
Infect Disord Drug Targets 2014;14(2):110-116. https://doi.org/10.2174/1871526514666141021112855
24. Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission 
in households: A cluster randomised trial. Ann Intern Med 2009;151(7):437-446. https://doi.
org/10.7326/0003-4819-151-7-200910060-00142
25. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the 
spread of respiratory viruses. Cochrane Database Syst Rev 2011(7):CDC006207. https://doi.
org/10.1002/14651858.CD006207.pub4
26. Jefferson T, Jones M, Al Ansari LA, et al. Physical interventions to interrupt or reduce the spread 
of respiratory viruses. Part 1. Face masks, eye protection and person distancing: Systematic review 
and meta-analysis. medRxiv 2020:2020.03.30.20047217. https://doi.org/10.1101/2020.03.30.20047217
27. Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-
to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. 
Lancet 2020;395(10242):1973-1987. https://doi.org/10.1016/S0140-6736(20)31142-9
28. Fisher EM, Noti JD, Lindsley WG, Blachere FM, Shaffer RE. Validation and application of models 
to predict facemask influenza contamination in healthcare settings. Risk Anal 2014;34(8):1423-1434. 
https://doi.org/10.1111/risa.12185
29. Osterholm MT, Moore KA, Kelley NS, et al. Transmission of Ebola viruses: What we know and what we 
do not know? mBio 2015;6(2):e00137. https://doi.org/10.1128/mBio.00137-15
30. Greenhalgh T, Papoutsi C. Studying complexity in health services research: Desperately seeking an 
overdue paradigm shift. BMC Med 2018;16(1):95. https://doi.org/10.1186/s12916-018-1089-4
31. Greenhalgh T, Schmid MB, Czypionka T, Bassler D, Gruer L. Face masks for the public during the 
COVID-19 crisis. BMJ 2020;369:m1435. https://doi.org/10.1136/bmj.m1435
32. Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science 
2020;368(6494):948-950. https://doi.org/10.1126/science.abc5312
Accepted 24 November 2020.
